Amlitelimab, dosed every four weeks or every 12 weeks, demonstrated statistically significant and clinically meaningful efficacy in skin clearance and disease severity compared to placebo at Week 24, ...

Merck, known as MSD outside of the United States and Canada, announced positive topline results from the phase 3 CORALreef Lipids trial evaluating the safety and efficacy of enlicitide decanoate, an ...

Enlicitide is the first oral PCSK9 inhibitor to demonstrate statistically significant and clinically meaningful reductions in LDL-C compared to placebo in Phase 3 trials RAHWAY, N.J.--(BUSINESS WIRE)- ...

Positive results from the global COAST 1 phase 3 study (clinical study identifier: NCT06130566) showed that amlitelimab, a fully human non-T cell depleting monoclonal antibody that targets OX40-ligand ...

AI-generated summary reviewed by our newsroom. Read our AI Policy. I had passed Yummm Donut so many times that the storefront no longer registered, just another blur of cement and plate glass between ...

Army football visits Kansas State during Fort Riley Day for a unique road game. Coach Jeff Monken expects crowd support due to military ties and local soldiers. K-State plans pregame military tributes ...

Se hai scelto di non accettare i cookie di profilazione e tracciamento, puoi aderire all’abbonamento "Consentless" a un costo molto accessibile, oppure scegliere un altro abbonamento per accedere ad ...

Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis Amlitelimab, dosed every four weeks or every 12 weeks, ...

Despite years of engagement in a global chip war, China remains a vital operation base for several Asian-grown champions. But even from afar, Washington still holds key levers of power. The latest ...

Some 13% of people claiming asylum in the year to June 2025 originally arrived in the UK on a study visa (David Angel/Alamy) The Government has announced it is cracking down on the number of students ...